Actuate Therapeutics, Inc. Common stock (ACTU) — Financial Flexibility Index
Actuate Therapeutics, Inc. Common stock (ACTU) has a Financial Flexibility Index of -0.99x as of September 2025. Free cash flow of $-6.68 Million (operating CF $-6.68 Million minus capex $3.00) represents -1% of total liabilities ($6.78 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Actuate Therapeutics, Inc. Common stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Actuate Therapeutics, Inc. Common stock across 3 annual periods. See ACTU working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Actuate Therapeutics, Inc. Common stock (2022–2024)
Year-by-year free cash flow to debt coverage for Actuate Therapeutics, Inc. Common stock. For the full company profile including market capitalisation, see market value of Actuate Therapeutics, Inc. Common stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-21.84 Million | $-21.84 Million | $9.21 Million | ▼ -1024.9% |
| 2023 | -0.21x | $-21.63 Million | $-21.63 Million | $102.62 Million | ▲ +93.3% |
| 2022 | -3.15x | $-17.79 Million | $-17.79 Million | $5.65 Million | — |